{"DataElement":{"publicId":"3290702","version":"1","preferredName":"Breast Carcinoma Margin Involvement Type","preferredDefinition":"Identification of the extent of margin involvement with breast carcinoma based on an operative procedure.","longName":"2783018v1.0:3290698v1.0","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"2783018","version":"1","preferredName":"Breast Positive Surgical Margin Involvement Extent","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:definition pending_To have a connection by participation or association or use; sharing in an activity or process.:The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","longName":"2431276v1.0:2782702v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431276","version":"1","preferredName":"Breast Positive Surgical Margin","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:definition pending","longName":"C12971:C48620","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Surgical Margin","conceptCode":"C48620","definition":"Indicates the presence of tumor cells at the edge of a surgically excised specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF14D-AD7F-3A55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2782702","version":"1","preferredName":"Involvement Extent","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.:The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","longName":"C25548:C25332","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Extent","conceptCode":"C25332","definition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"569276BA-E5DC-2F3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"ONEDATA","dateModified":"2008-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5691DE76-2C6F-29EB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"9/28/10 Released for use in caTissue Suite version 1.1 and/or 1.2 per owners direction.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3290698","version":"1","preferredName":"Breast Carcinoma Margin Involvement Type","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002_Margin; the boundary line or the area immediately inside the boundary._To have a connection by participation or association or use; sharing in an activity or process._Type; a subdivision of a particular kind of thing.","longName":"3290698v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Multiple margins","valueDescription":"Multiple Surgical Margin","ValueMeaning":{"publicId":"3290699","version":"1","preferredName":"Multiple Surgical Margin","longName":"3290699","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold. (dictionary.com): The edge or border of the tissue removed in cancer surgery.  The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed.  The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surgical Margin","conceptCode":"C41227","definition":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA2E17C-9D46-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEA2E17C-9D5F-204F-E040-BB89AD4335B7","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"ONEDATA","dateModified":"2011-10-06","deletedIndicator":"No"},{"value":"Single margin, extensive","valueDescription":"Extensive Single Surgical Margin","ValueMeaning":{"publicId":"3290700","version":"1","preferredName":"Extensive Single Surgical Margin","longName":"3290700","preferredDefinition":"Large in quantity, range, or spatial extent.: Not accompanied by another or others.: The edge or border of the tissue removed in cancer surgery.  The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed.  The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extensive","conceptCode":"C47863","definition":"Large in quantity, range, or spatial extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surgical Margin","conceptCode":"C41227","definition":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA2E17C-9D6D-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEA2E17C-9D86-204F-E040-BB89AD4335B7","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"ONEDATA","dateModified":"2011-10-06","deletedIndicator":"No"},{"value":"Single margin, focal","valueDescription":"Focal Single Surgical Margin","ValueMeaning":{"publicId":"3290701","version":"1","preferredName":"Focal Single Surgical Margin","longName":"3290701","preferredDefinition":"In terms of cancer, limited to a specific area.: Not accompanied by another or others.: The edge or border of the tissue removed in cancer surgery.  The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed.  The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Focal","conceptCode":"C28224","definition":"Limited to a specific area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surgical Margin","conceptCode":"C41227","definition":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA2E17C-9D94-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AEA2E17C-9DAD-204F-E040-BB89AD4335B7","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"ONEDATA","dateModified":"2011-10-06","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30755D22-FF29-FABF-E050-BB89AD435E5D","beginDate":"2016-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-04-14","modifiedBy":"ONEDATA","dateModified":"2016-04-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3290697","version":"1","preferredName":"Breast Carcinoma Margin Involvement Type","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:Margin; the boundary line or the area immediately inside the boundary.:To have a connection by participation or association or use; sharing in an activity or process.:Type; a subdivision of a particular kind of thing.","longName":"C4872:C25563:C25548:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Margin","conceptCode":"C25563","definition":"A boundary line or the area immediately inside the boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA2E17C-9D1D-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"ONEDATA","dateModified":"2011-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA2E17C-9D2E-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"REEVESD","dateModified":"2016-04-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461590","version":"1","longName":"Surgery Elements","context":"NCIP"},{"publicId":"3461588","version":"1","longName":"General Elements","context":"NCIP"}]},{"publicId":"3886753","version":"1","longName":"General Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902138","version":"1","longName":"General","context":"BOLD"}]},{"publicId":"3886759","version":"1","longName":"Surgery Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902142","version":"1","longName":"Surgery","context":"BOLD"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"2783018v1.0:3290698v1.0","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"If yes, describe the extent o","type":"Preferred Question Text","description":"If yes, describe the extent of margin involvement","url":null,"context":"BOLD"},{"name":"If yes, describe the extent of DCIS close to the margin","type":"Alternate Question Text","description":"If yes, describe the extent of DCIS close to the margin","url":null,"context":"NCIP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Describe the extent of margin involvement","url":null,"context":"Alliance"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AEA2E17C-9DB7-204F-E040-BB89AD4335B7","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"FORMBUILDER","dateModified":"2018-05-22","changeDescription":"Curated to support Breast Oncology Local Disease (BOLD) Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}